Ex Parte Wang et alDownload PDFPatent Trial and Appeal BoardApr 14, 201612539324 (P.T.A.B. Apr. 14, 2016) Copy Citation UNITED STA TES p A TENT AND TRADEMARK OFFICE APPLICATION NO. FILING DATE 12/539,324 08/11/2009 22827 7590 04/14/2016 DORITY & MANNING, PA POST OFFICE BOX 1449 GREENVILLE, SC 29602-1449 FIRST NAMED INVENTOR Qian Wang UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O. Box 1450 Alexandria, Virginia 22313-1450 www .uspto.gov ATTORNEY DOCKET NO. CONFIRMATION NO. USC-187 9088 EXAMINER ZOU, NIANXIANG ART UNIT PAPER NUMBER 1648 MAILDATE DELIVERY MODE 04/14/2016 PAPER Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte QIAN WANG and TAO LI Appeal2013-009455 Application 12/539,324 Technology Center 1600 Before DEMETRA J. MILLS, ERIC B. GRIMES, and JOHN G. NEW, Administrative Patent Judges MILLS, Administrative Patent Judge. DECISION ON APPEAL This is an appeal under 35 U.S.C. § 134. The Examiner has rejected the claims as unpatentable under 35 U.S.C. § 103(a) as being obvious. We have jurisdiction under 35 U.S.C. § 6(b ). We Affirm. Appeal2013-009455 Application 12/539,324 STATEMENT OF CASE The present Specification discloses core-shell bionanocomposites which can generally be described as having a polymeric core with biomacromolecules attached about the outer surface of the core to form a shell. Spec. 9. The Specification discloses a first method of making bionanocomposites based on self-assembly along with polymerization including emulsion and living polymerization. Spec. 10. The polymeric core may be P4VP (poly(4-vinylpyridine)) and the shell coating may be CPMV (cowpea mosaic virus). Spec. 12-14. The following claim is representative. 1. A bionanocomposite comprising a core comprising a polymer having pyridine functional groups, wherein the core defines an outer surface having a surface area; and a shell comprising a plurality of biomacromolecules, \~1herein the shell is positioned about the outer surface of the core such that the shell covers at least about 50% of the surface area of the polymeric core; wherein the polymer having pyridine functional groups non-covalently interacts with the biomacromolecules to form the bionanocomposite. 11. A method of forming a bionanocomposite defining a shell and a core, the method comprising non-covalently attaching biomacromolecules about a polymeric core, wherein the polymeric core comprises a polymer having pyridine functional groups and defines an outer surface having a surface area, and wherein the biomacromolecules cover at least about at least about 50% of the surface area of the polymeric core to form a shell. 2 Appeal2013-009455 Application 12/539,324 Cited References Justin T. Russel et al., Self-Assemble and Cross-Linking of Bionanoparticles at Liquid-Liguid Interfaces, 44 ANGEW. CHEM. INT. ED., 2420-2426 (2005). Syuji Fujii et al., Stimulus-Responsive Particulate Emulsifiers Based on Lightly Cross-Linked Poly(4-vinylpyridine)-Silica Nanocomposite Microgels, 22 LANGMUIR, 6818---6825 (2006). Additional Reference Rembamn 1 et al., Grounds of Rejection us 4,259 ,223 Mar. 3 1, 19 81 Claims 1-3, 6-8, 10-16, 19, and 20 were rejected under 35 U.S.C. §103(a) as being unpatentable over Russel and Fujii. FINDINGS OF FACT The Examiner's findings of fact are set forth in the i~\'.l.ns\~1er at pages 3-8. The following facts are highlighted. 1. Russell teaches a bionanocomposite comprising a core of perfluorodecalin droplets and a shell of CPMV particles segregated at the perfluorodecalin-water interface, thus, stabilizing the dispersion of the oil droplets; see e.g., para. 1, fight col. p. 2420. 1 Rembaum was cited in the Answer, page 6, but is not cited by the Examiner in the statement of rejection. According to the Examiner, Rembaum teaches that a microsphere made of polyvinyl pyridine binds to RNA, DNA, virus, and bacteria. This teaching further strengthens the ground of rejection based on Russell and Fujii. We do not include Rembaum as a cited reference as it has not been properly cited by the Examiner. 3 Appeal2013-009455 Application 12/539,324 2. The bionanocomposite of Russel has a diameter from about 10 to about 100 nanometers. Ans. 3. 3. Russell also teaches a method of forming the bionanocomposite, comprising non-covalently attaching biomacromolecules about a polymeric core by combining an organic solution containing the perfluorodecalin with an aqueous solution containing the CPMV to form an emulsion; mixing the emulsion; and removing the organic solvent by evaporating; see e.g., para. 1, right col. p. 2421 and para. 1, right col. p. 2422.8. 4. Russell does not teach that: (1) the core is made of "a polymer having pyridine functional groups", specifically poly( 4-vinylpyridine ); and "the shell covers at least about 50% of the surface area of the polymeric core" (Claims 1, 8, and 11 ). Ans. 3--4. 5. Fujii teaches a silica nanocomposite microgel particle (P4VP-Si02), wherein poly( 4-vinylpyridine) is the polymer core, and the shell covers at least about 50% of the surface area of the polymeric core; see e.g., the bridging para. between left and right col. p. 6819, and para. 2, left col. p. 6821. 6. Fujii discloses pH responsive, stable, nanoparticles made of poly( 4-vinylpyridine) para. 1 and 2, left col. p. 6821. 4 Appeal2013-009455 Application 12/539,324 7. Fujii, page 6818, first column, discloses that The use of colloidal particles to prepare and stabilize emulsions (so-called "Pickering emulsions"[2]) has been recognized for over a century .... Most of the literature is concerned with various types of inorganic particles such as silica, barium sulfate, calcium carbonate, or carbon black, although recently there have been several interesting examples of organic particles used as particulate emulsifiers. Emphasis added. 8. Fujii, page 6818, second column, discloses that Russell et al. used ultrafine CdSe sols8 and 30 nm cowpea mosaic virus particles ... as nanoscale particulate emulsifiers to stabilize either oil-in-water and/or water-in-oil emulsions. It was demonstrated that these nanoparticles assembled at the droplet interface and could be subsequently cross-linked so as to stabilize these superstructures. PRINCIPLES OF LAW In making our determination, 'lie apply the preponderance of the evidence standard. See, e.g., Ethicon, Inc. v. Quigg, 849 F.2d 1422, 1427 2 A Pickering emulsion is an emulsion that is stabilized by solid particles (for example colloidal silica) which adsorb onto the interface between the two phases. This type of emulsion was named after S.U. Pickering, who described the phenomenon in 1907, although the effect was first recognized by Walter Ramsden in 1903. If oil and water are mixed and small oil droplets are formed and dispersed throughout the water, eventually the droplets will coalesce to decrease the amount of energy in the system. However, if solid particles are added to the mixture, they will bind to the surface of the interface and prevent the droplets from coalescing, thus, causing the emulsion to be more stable. https://en.wikipedia.org/wiki/ Pickering_emulsion. 5 Appeal2013-009455 Application 12/539,324 (Fed. Cir. 1988) (explaining the general evidentiary standard for proceedings before the Office). "In rejecting claims under 35 U.S.C. § 103, the examiner bears the initial burden of presenting a prima facie case of obviousness. Only if that burden is met, does the burden of coming forward with evidence or argument shift to the applicant." In re Rijckaert, 9 F.3d 1531, 1532 (Fed. Cir. 1993). Obviousness - Russel in view of Fujii We find that the Examiner has provided evidence to support a prima facie case of obviousness. We provide the following additional comment to the Examiner's argument set forth in the Final Action and Answer. Appellants only provide argument for independent claims 1 and 11 as a group in the Brief (p. 3-5). The Examiner concludes from the listed findings of fact, herein, that It would have been prima facie obvious to one of ordinary skill in the art at the time the invention was made to substitute the perfluorodecalin droplets of Russell's for the polymer ofpoly(4-vinylpyridine) ofFujii's in order to make a ... bionanocomposite. One skilled in the art would have been motivated to generate the claimed invention with a reasonable expectation of success, given the success of the prior art that CPMV particles can be assembled at the droplet interface, resulting a in bionanocomposite, as illustrated by Russell, and also given that poly( 4-vinylpyridine) can be polymer core of a nanoparticle, and act as pH-responsive emulsifier of a nanoparticle, as taught by Fujii. Therefore, the invention as a whole was clearly prima facie obvious to one of ordinary skill in the art at the time the invention was made. Ans. 4--5. 6 Appeal2013-009455 Application 12/539,324 Appellants contend that In making the rejection, the Examiner apparently assumes that the interaction between poly( 4-vinylpyridine) and biomacromolecules (as taught by Russell) would perform the same as the interaction between poly( 4-vinylpyridine) and silica particles (as taught by Fujii). This assumption is completely unfounded, and finds no support in the references. Instead, one of ordinary skill in the art would have readily recognized that the interaction between poly( 4-vinylpyridine) and biomacromolecules (e.g., CPMV) would not be the same as the interaction between poly( 4-vinylpyridine) and silica particles. Br. 4--5. Appellants further argue that The Examiner refers to the Fijii's [sic] introductory paragraphs, which discusses others' works, and states that this discussion bridges the divide between inorganic particles and organic particles. This discussion, however, expressly distinguishes various inorganic particles and organic particles in its second sentence. There is simply no support in the teachings of either cited reference for the Examiner's statement that "silica particles are just an example used as emulsifier in the study on poly( 4-vinylpyridine) nanocomposite." (Final Office Action, page 6). Br. 5. Finally, Appellants argue that Russell teaches that crosslinking is required or essential to the formation of stable particles. Br. 6. We conclude that the Examiner has established a prima facie case of obviousness on the evidence before us which has not been rebutted by Appellants. Both Russel and Fujii disclose the formation of Pickering emulsions. Russel, page 2420, col. 2, 1. 2; Fujii, page 6818, col. 1. Russel discloses a Pickering emulsion comprised of a perfluorodecalin droplet/particle coated with an organic CPMV. Rusell, p. 2422, col. 2. Fujii discloses a Pickering emulsion comprised of poly( 4-vinylpyridine) particle 7 Appeal2013-009455 Application 12/539,324 with an inorganic Si02 coating. Fig. 1. Fujii discloses that other particulate polymers may also be used in Pickering emulsions, including poly(2- ( dimethylamino )ethyl methacrylate )-based diblock copolymer and po 1 ystyrene/po ly[2-( dimethy lamino )ethyl methacry late-stat-ethylene glyco 1 dimethacrylate. P. 6829, col. 1. Thus, it would have been obvious to one of ordinary skill in the art at the time of the invention that numerous types of Pickering emulsions could have been prepared using various particles and coating materials, including organic and inorganic coating materials known in the art as disclosed in Fujii and Russel. After that burden is met, the burden of coming forward with evidence or argument to rebut the Examiner's prima facie case shifts to the applicant. In re Rijckaert, 9 F.3d 1531, 1532 (Fed. Cir. 1993). Appellants have not established with evidence or argument that one of ordinary skill in the art would not have expected that the substitution of one oil droplet/particle or polymer for another in a Pickering emulsion would not form a bionanocomposite, as claimed. Appellants argue that one of ordinary skill in the art would have readily recognized that the interaction between poly( 4- vinylpyridine) and biomacromolecules (e.g., CPMV) would not be the same as the interaction between poly( 4-vinylpyridine) and silica particles. However, Appellants adduce no evidence of record in support of this contention and their arguments are therefore only attorney argument and do not constitute evidence that one of ordinary skill in the art would not have expected poly( 4-vinylpyridine) and CPMV to form bionanoparticles based on the disclosures of the cited references. See In re Pearson, 494 F.2d 1399, 8 Appeal2013-009455 Application 12/539,324 1405 (CCPA 1974) ("Attorney's argument in a brief cannot take the place of evidence."). As to Appellants' arguments that both Russel and Fujii require cross- linking between the particle and coating (App. Br. 6-7) and teach way from non-crosslinked particle/coating interactions, we are not persuaded. Russel studied force-deformation measurements on droplets with particle assemblies that were both non-cross-linked and cross-linked using glutaraldehyde. Russel, p. 2424, col 2. Thus, Russel discloses the preparation of non-crosslinked droplet/particle assemblies. P. 2424, col. 2. Likewise, Fujii describes that, "Non-cross-linked nanocomposite particles were ... synthesized in the absence of any cross-linking monomer using the protocol described by Percy et al." P. 6820, col. 1. Therefore, while the cited references disclose that cross-linked droplet/particle assemblies were preferred for use in a low pH environment (not within the scope of claims 1 and 11 ), each of the cited references discloses that the preparation of non- crosslinked coated droplet or polymer assemblies was known at the time of the invention. A preponderance of the evidence does not support patentability and the obviousness rejection is affirmed for the reasons of record. CONCLUSION OF LAW The cited references support the Examiner's obviousness rejection, which is affirmed for the reasons of record, and herein. 9 Appeal2013-009455 Application 12/539,324 TIME PERIOD No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136(a). AFFIRMED 10 Copy with citationCopy as parenthetical citation